IBM unveils AI-powered fingernail sensor that can monitor Parkinson’s progression

News

Author: Roisin McCormackPublished: 16 January 2019

Prep: Cook: Serves:

US information technology giant IBM has unveiled a prototype of the first artificial intelligence (AI) powered fingernail sensor designed to track disease progression.

The AI system – a wireless device that attaches to the fingernail – monitors the movement of the patient’s nail and calculates their grip strength.

Data gathered is then used to determine how the wearer’s grip has changed over time, and also tracks symptoms such as bradykinesia, tremor and dyskinesia.

Katsuyuki Sakuma, a researcher at IBM’s Thomas J. Watson Research Centre, New York US, said: “Our fingernails deform — bend and move — in stereotypic ways when we use them for gripping, grasping, and even flexing and extending our fingers. This deformation is usually on the order of single digit microns and not visible to the naked eye.

“By pushing computation to the end of our fingers, we’ve found a new use for our nails by detecting and characterising their subtle movements.”

To read more on this topic click here.

For more information on Parkinson’s assessment tools please visit the EPDA website.

Read more:

Inhalable drug given green light

Researchers create Parkinson’s-resistant stem cells

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

The road to Copenhagen: The UK Parkinson’s Football Team

We talk to team captain Charlie Appleyard

‘7 Years of Camera Shake’: photographer with Parkinson’s publishes inspiring coffee table book

David Plummer describes his journey as a wildlife photographer

Who said what: QoTW 11.06.15

Our favourite quotes of the week from around the web

New wearable medical device for Parkinson’s disease to launch this year

The Imperial College London Innovation Fund, UK, has invested £205,000 to support UK-based tech company Charco Neurotech in its development of a non-invasive medical device for people with Parkinson’s disease. CUE1, a circular device that attaches to the sternum with medical adhesives, uses specialised vibration to help alleviate physical symptoms of Parkinson’s disease. Initial user testing among people with the condition found that the device improved movement by an average of 16%, with testers reporting benefits for walking and fine motor tasks. Lucy Jung, CEO and co-founder of Charco Neurotech, said: “We believe that CUE1 has the potential to significantly improve [Parkinson’s disease] symptoms through its unique controlled vibration technology. We are excited to continue our work on the device and we look forward to the outcome of our proposed clinical trials.” Charco Neurotech will use the Imperial College investment to initiate a clinical trial and fund the device’s manufacture for…

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”

Could a prostate drug lower the risk of Parkinson’s disease?

Researchers in the US, Denmark and China have found that a type of medication used to treat enlarged prostate, known as alpha-blockers, is associated with a lower risk of Parkinson’s disease. As part of the study, the research team analysed patient data from 150,000 men using medications like the alpha-blocker terazosin – which has previously been shown to slow Parkinson’s disease progression in animals – and compared their findings to data from 150,000 men using the alpha-blocker tamsulosin. They found that men taking terazosin were 12 to 37% less likely to develop Parkinson’s disease. Jacob Simmering, corresponding author of the study, said: “Despite the relative differences in population and health care system structure, we found a similar protective effect in both [the US and Denmark]. “If these results are confirmed through further investigation, especially a randomised clinical trial, terazosin may provide neuroprotection and potentially prevent – and not just manage…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

IBM unveils AI-powered fingernail sensor that can monitor Parkinson’s progression

News

Author: Roisin McCormackPublished: 16 January 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

The road to Copenhagen: The UK Parkinson’s Football Team

Perspectives

‘7 Years of Camera Shake’: photographer with Parkinson’s publishes inspiring coffee table book

Perspectives

Who said what: QoTW 11.06.15

New wearable medical device for Parkinson’s disease to launch this year

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

Could a prostate drug lower the risk of Parkinson’s disease?

{title}

Subscribe

IBM unveils AI-powered fingernail sensor that can monitor Parkinson’s progression

News

Author: Roisin McCormackPublished: 16 January 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

The road to Copenhagen: The UK Parkinson’s Football Team

Perspectives

‘7 Years of Camera Shake’: photographer with Parkinson’s publishes inspiring coffee table book

Perspectives

Who said what: QoTW 11.06.15

New wearable medical device for Parkinson’s disease to launch this year

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

Could a prostate drug lower the risk of Parkinson’s disease?

{title}

Subscribe

Sign in